openPR Logo
Press release

Portal Hypertension Market Growth Projections 2023-2032: DelveInsight Analysis | Boehringer Ingelheim, Gilead Sciences, Novartis, Cumberland Pharma, Conatus, Onyx Therapeutics, Inc.

05-26-2025 03:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Portal Hypertension Market Growth Projections 2023-2032:

The Key Portal Hypertension Companies in the market include - Boehringer Ingelheim, Galectin Therapeutics Inc., Onyx Therapeutics, Inc., Novartis, Cumberland Pharma, Conatus Pharma, Ferozsons Laboratories Ltd., Histogen, Gilead Sciences, Galectin Therapeutics Inc., and others.

DelveInsight's "Portal Hypertension Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Portal Hypertension, historical and forecasted epidemiology as well as the Portal Hypertension market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Portal Hypertension market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Portal Hypertension Market Forecast [http://delveinsight.com/sample-request/portal-hypertension-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Portal Hypertension Market Report:

*
The Portal Hypertension market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

*
In May 2025, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company specializing in innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH), today reported encouraging two-year outcomes from the open-label compensated MASH cirrhosis (F4c) cohort of the Phase 3 MAESTRO-NAFLD-1 trial evaluating Rezdiffra. The 122 patients enrolled showed notable improvements from baseline in liver stiffness, liver fat content, fibrosis biomarkers, liver volume, and clinically significant portal hypertension (CSPH) risk scores.

*
Around 2000 Americans per 100,000 have liver cirrhosis in the United States, and more than 90% of those who have cirrhosis go on to develop portal hypertension, according to National Institutes of Health (n.d.)

*
Although it is likely similar to that of the US, the international incidence of portal hypertension is similarly unknown, with variances mostly in the underlying reasons. The major causes of portal hypertension and esophageal varices in Western countries are alcoholic and viral cirrhosis; at the time of diagnosis, gastroesophageal varices are present in 30% of patients with compensated cirrhosis and 60-70% of patients with decompensated cirrhosis

*
Portal hypertension, a disease that precedes the bulk of cirrhotic patients' deaths, eventually develops in about 90% of cirrhotic patients

*
Key Portal Hypertension Companies: Boehringer Ingelheim, Galectin Therapeutics Inc., Onyx Therapeutics, Inc., Novartis, Cumberland Pharma, Conatus Pharma, Ferozsons Laboratories Ltd., Histogen, Gilead Sciences, Galectin Therapeutics Inc., and others

*
Key Portal Hypertension Therapies: BI 685509, GR-MD-02, Sorafenib, Serelaxin, Ifetroban, IDN-6556, Terlipressin, Emricasan, Ambrisentan, belapectin, and others

*
The Portal Hypertension epidemiology based on gender analyzed that portal hypertension affects males slightly more than females

*
The Portal Hypertension market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Portal Hypertension pipeline products will significantly revolutionize the Portal Hypertension market dynamics.

Portal Hypertension Overview

A rise in the pressure inside the portal vein, which conducts blood from the digestive system to the liver, is known as portal hypertension. A obstruction in the blood flow through the liver is the root cause of the rise in pressure. Large veins (varices) grow across the oesophagus and stomach to get past the blockage as a result of increased pressure in the portal vein. The varices deteriorate and become more prone to bleeding.

Get a Free sample for the Portal Hypertension Market Report

https://www.delveinsight.com/report-store/portal-hypertension-market [https://www.delveinsight.com/report-store/portal-hypertension-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Portal Hypertension Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Portal Hypertension Epidemiology Segmentation:

The Portal Hypertension market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

*
Total Prevalence of Portal Hypertension

*
Prevalent Cases of Portal Hypertension by severity

*
Gender-specific Prevalence of Portal Hypertension

*
Diagnosed Cases of Episodic and Chronic Portal Hypertension

Download the report to understand which factors are driving Portal Hypertension epidemiology trends @ Portal Hypertension Epidemiology Forecast [http://delveinsight.com/sample-request/portal-hypertension-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Portal Hypertension Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Portal Hypertension market or expected to get launched during the study period. The analysis covers Portal Hypertension market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Portal Hypertension Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Portal Hypertension Therapies and Key Companies

*
BI 685509: Boehringer Ingelheim

*
GR-MD-02: Galectin Therapeutics Inc.

*
Sorafenib: Onyx Therapeutics, Inc.

*
Serelaxin: Novartis

*
Ifetroban: Cumberland Pharma

*
IDN-6556: Conatus Pharma

*
Terlipressin: Ferozsons Laboratories Ltd.

*
Emricasan: Histogen

*
Ambrisentan: Gilead Sciences

*
belapectin: Galectin Therapeutics Inc.

Discover more about therapies set to grab major Portal Hypertension market share @ Portal Hypertension Treatment Market [http://delveinsight.com/sample-request/portal-hypertension-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Scope of the Portal Hypertension Market Report

*
Study Period: 2019-2032

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Portal Hypertension Companies: Boehringer Ingelheim, Galectin Therapeutics Inc., Onyx Therapeutics, Inc., Novartis, Cumberland Pharma, Conatus Pharma, Ferozsons Laboratories Ltd., Histogen, Gilead Sciences, Galectin Therapeutics Inc., and others

*
Key Portal Hypertension Therapies: BI 685509, GR-MD-02, Sorafenib, Serelaxin, Ifetroban, IDN-6556, Terlipressin, Emricasan, Ambrisentan, belapectin, and others

*
Portal Hypertension Therapeutic Assessment: Portal Hypertension current marketed and Portal Hypertension emerging therapies

*
Portal Hypertension Market Dynamics: Portal Hypertension market drivers and Portal Hypertension market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Portal Hypertension Unmet Needs, KOL's views, Analyst's views, Portal Hypertension Market Access and Reimbursement

To know more about Portal Hypertension companies working in the treatment market, visit @ Portal Hypertension Clinical Trials and Therapeutic Assessment [http://delveinsight.com/sample-request/portal-hypertension-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Portal Hypertension Market Report Introduction

2. Executive Summary for Portal Hypertension

3. SWOT analysis of Portal Hypertension

4. Portal Hypertension Patient Share (%) Overview at a Glance

5. Portal Hypertension Market Overview at a Glance

6. Portal Hypertension Disease Background and Overview

7. Portal Hypertension Epidemiology and Patient Population

8. Country-Specific Patient Population of Portal Hypertension

9. Portal Hypertension Current Treatment and Medical Practices

10. Portal Hypertension Unmet Needs

11. Portal Hypertension Emerging Therapies

12. Portal Hypertension Market Outlook

13. Country-Wise Portal Hypertension Market Analysis (2019-2032)

14. Portal Hypertension Market Access and Reimbursement of Therapies

15. Portal Hypertension Market Drivers

16. Portal Hypertension Market Barriers

17. Portal Hypertension Appendix

18. Portal Hypertension Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=portal-hypertension-market-growth-projections-20232032-delveinsight-analysis-boehringer-ingelheim-gilead-sciences-novartis-cumberland-pharma-conatus-onyx-therapeutics-inc]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Portal Hypertension Market Growth Projections 2023-2032: DelveInsight Analysis | Boehringer Ingelheim, Gilead Sciences, Novartis, Cumberland Pharma, Conatus, Onyx Therapeutics, Inc. here

News-ID: 4036274 • Views:

More Releases from ABNewswire

The Boulder Group Arranges Sale of Net Leased North Carolina Walgreens
The Boulder Group Arranges Sale of Net Leased North Carolina Walgreens
The Boulder Group, a net leased investment brokerage firm completed the sale of a single tenant Walgreens located at 219 Rodney Orr Bypass in Robbinsville, North Carolina for $2,875,000. The 9,665-square-foot building is strategically located along Rodney Orr Bypass, the primary thoroughfare in Robbinsville, which sees over 10,000 vehicles per day. The property is surrounded by major retailers, including Ace Hardware, McDonald's, Wendy's, Carquest, and Dollar General, all of which generate
Gold Prices Are Rising Again - Gilbert Gold Buyers Encourages Arizona Residents to Cash In at Top Dollar
Gold Prices Are Rising Again - Gilbert Gold Buyers Encourages Arizona Residents …
With gold prices rising, Gilbert Gold Buyers urges residents in Gilbert, Mesa, Chandler, and Tempe to sell unwanted gold and silver. The trusted Arizona gold dealer pays top dollar - no amount too small. As gold prices surge once again, Gilbert Gold Buyers, a trusted and established gold dealer in Gilbert, Arizona, is encouraging residents throughout the East Valley to take advantage of the rising market. With values climbing and buyer
Nouvelle Towns Launches in Oshawa, Offering Attainable Entry Into First-Time Homeownership
Nouvelle Towns Launches in Oshawa, Offering Attainable Entry Into First-Time Hom …
Boutique 26-suite townhome community in Oshawa offers attainable first-time ownership and wealth-building. Image: https://www.abnewswire.com/upload/2025/12/f1bbe2ebd72604b777c34571e5bf3779.jpg Oshawa, Ontario - In a market where many first-time buyers feel shut out, Build Up Development Co. is redefining the entry point to homeownership with the launch of Nouvelle Towns, a 27-suite modern townhome community in North Oshawa. The project emphasizes long-term wealth-building potential through homeownership, placing first-time buyers on a path toward generational wealth. Your first home isn't
Ecuadorian Rainforest Joins the Organic Trade Association at Food Ingredients Europe 2025
Ecuadorian Rainforest Joins the Organic Trade Association at Food Ingredients Eu …
The company highlights the strength of the U.S. organic sector while connecting with global buyers in Paris. Image: https://www.abnewswire.com/upload/2025/12/c03e2070716870008c105c5ebccafded.jpg Clifton, NJ - Ecuadorian Rainforest, LLC participated alongside the Organic Trade Association (OTA) at Food Ingredients Europe 2025 in Paris, France. The event brought together international food and nutrition professionals, offering a valuable platform for showcasing the depth and quality of U.S. organic ingredients. The company reported a successful show, noting strong interest in

All 5 Releases


More Releases for Portal

Travel Portal Development Company
Rayds Services Limited Announces Unified Hotel Data Platform for Seamless API Integration Mumbai, India - Rayds Services Limited, a leading travel technology innovator, has launched its unified hotel data platform designed to simplify API integration and data synchronization across multiple travel suppliers. The platform enables travel agencies, OTAs, and hotel booking systems to connect, map, and manage data from providers such as TBO, Tripjack, and GRN through a single interface. By automating
Patient Portal Market: Portal to Progress - Opportunities and Strategies 2024
The patient portal market size has grown exponentially in recent years. It will grow from $4.45 billion in 2023 to $5.34 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to growing demand for patient engagement and self-service healthcare, regulatory incentives promoting the adoption of electronic health records (ehrs), increased focus on healthcare interoperability
10genjobs: Launch of Portal
Rajasthan, 27 June, 2021: Founder of 10GenJobs, Ashok Zutshi today announced the launch of its portal, 10GenJobs.in for Jobs In Rajasthan. We aim to help job seekers as well as recruiters by using Artificial Intelligence to match the candidate profile to the job that employers post. With a huge database of jobs in 250 towns and cities in Rajasthan including Jaipur, Udaipur, Kota, Jodhpur, Ajmer, etc; and tie-ups with more
Global Board Portal Market 2019 : Passageways, Directorpoint, BoardPaq, Eshare, …
Board Portal Market 2019 Research report contains a qualified and in-depth examination of Board Portal Market. At first, the report provides an overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. It also covers detailed competitive outlook including the Board Portal market share and company profiles of the key participants operating in the global market. Short Description about Board
Enterprise Portal Market Report 2018: Segmentation by Type (Information Portal, …
Global Enterprise Portal market research report provides company profile for Red Hat, Inc. (U.S.), Liferay, Inc (U.S.), Sitecore (Denmark), Iflexion (U.S.), Tata Consultancy Services Limited (India), Infosys Limited (India), HCL Technologies Limited (India) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
Patient Portal Software Market
Patient Portal Software Market The study on the global Patient Portal Software Market which is backed by extensive primary and detailed secondary research, involving numerous static databases, national government documentation, latest news articles, press releases, company annual reports, financial reports, pertinent patent and administrative databases, as well as a range of internal and external proprietary databases. Request for a free sample report @ https://www.reportsmonitor.com/request_sample/105448 Giving a fleeting introduction to the prerequisites of the industry, the report starts